James B. Breitmeyer

Director, Vaxart.

Companies

VaxartBoard member May 1, 2026 to now¹
Oncternal Therapeutics, Inc.Board member Jun 11, 2019 to Feb 15, 2024²
Oncternal Therapeutics, Inc.Chief executive officer Jun 11, 2019 to Feb 15, 2024²
Otonomy (United States)Board member Jun 20, 2018 to Jun 23, 2022³
Zogenix (United States)Board member Mar 26, 2014 to Mar 9, 2022⁴
Oncternal Therapeutics, Inc.President Jun 11, 2019 to Jun 20, 2019²

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jul 16, 2026Granted 8,315 shares of Vaxart⁵
Apr 23, 2026Granted 78,800 shares of Vaxart⁸
Jan 3, 2024Shares withheld for tax 4,485 shares at $0.50 of Oncternal Therapeutics, Inc.⁶
Jan 3, 2024Shares withheld for tax 50,955 shares at $0.50 of Oncternal Therapeutics, Inc.⁶
Jul 3, 2023Shares withheld for tax 4,007 shares at $0.36 of Oncternal Therapeutics, Inc.⁹
Jul 3, 2023Shares withheld for tax 47,992 shares at $0.36 of Oncternal Therapeutics, Inc.⁹
Apr 14, 2023Bought 2,250 shares at $0.29 of Oncternal Therapeutics, Inc.¹⁰
Apr 14, 2023Bought 47,750 shares at $0.30 of Oncternal Therapeutics, Inc.¹⁰
Apr 13, 2023Bought 100,000 shares at $0.29 of Oncternal Therapeutics, Inc.¹⁰
Jan 3, 2023Shares withheld for tax 1,325 shares at $1.02 of Oncternal Therapeutics, Inc.¹¹
Jan 3, 2023Shares withheld for tax 27,793 shares at $1.02 of Oncternal Therapeutics, Inc.¹¹
Jul 28, 2022Granted 18,750 shares of Oncternal Therapeutics, Inc.¹²
Jul 28, 2022Granted 185,625 shares of Oncternal Therapeutics, Inc.¹²
Mar 7, 2022U 1,250 shares of Zogenix (United States)⁷
Jan 27, 2022Bought 25,000 shares at $1.68 of Oncternal Therapeutics, Inc.¹³
Jan 3, 2022Granted 6,793 shares of Oncternal Therapeutics, Inc.¹⁴
Jan 3, 2022Granted 128,557 shares of Oncternal Therapeutics, Inc.¹⁴

The numbers on this page point here. Each one links to the record it came from.